Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton.
about
beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteinsEnhancement of scleral macromolecular permeability with prostaglandinsNovel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeProstaglandins regulate nuclear localization of Fascin and its function in nucleolar architecture.Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathwayProstaglandins and inflammation.PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease.Prostaglandin F(2alpha) receptor in the corpus luteum: recent information on the gene, messenger ribonucleic acid, and protein.Effects of prostaglandin analogues on aqueous humor outflow pathways.Prostaglandins in the eye: Function, expression, and roles in glaucoma.Prostaglandins in cancer cell adhesion, migration, and invasionDrosophila Fascin is a novel downstream target of prostaglandin signaling during actin remodeling.Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.Three paradigms of airway smooth muscle hyperresponsiveness in young guinea pigs.F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cellsPGF(2alpha) stimulates FP prostanoid receptor mediated crosstalk between Ras/Raf signaling and Tcf transcriptional activation.Activation of the human FP prostanoid receptor disrupts mitosis progression and generates aneuploidy and polyploidy.Prostaglandins temporally regulate cytoplasmic actin bundle formation during Drosophila oogenesisUsing label-free screening technology to improve efficiency in drug discovery.Cyclooxygenase metabolites in the kidney.Positive and negative effects of prostaglandins in Alzheimer's disease.Differential gene expression in the bovine corpus luteum during transition from early phase to midphase and its potential role in acquisition of luteolytic sensitivity to prostaglandin F2 alpha.Who is the real 12-HETrE?Suppression of adipocyte differentiation by aldo-keto reductase 1B3 acting as prostaglandin F2alpha synthase.LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptor.Distinct regions of the cadherin cytoplasmic domain are essential for functional interaction with Galpha 12 and beta-catenin.FP prostanoid receptor activation of a T-cell factor/beta -catenin signaling pathway.Delayed reversal of shape change in cells expressing FP(B) prostanoid receptors. Possible role of receptor resensitization.Prostaglandins and rheumatoid arthritis.Abnormal Expression of Prostaglandins E2 and F2α Receptors and Transporters in Patients with Endometriosis.Induction of angiogenic immediate early genes by activation of FP prostanoid receptors in cultured human ciliary smooth muscle cells.Regulation of heme oxygenase expression by cyclopentenone prostaglandins.PGF2α regulates the basolateral K channels in the distal convoluted tubule.Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin.
P2860
Q24292014-EFDC2AD2-5E61-47FD-9728-C3F29F1C5EF3Q28345276-5A5DCF3C-3DA5-4CFE-A6B9-28193A61159CQ28586698-E3B50894-4548-4E6B-A29E-E9118ECEC80FQ30651049-B786312B-29C1-4B00-8E98-D89B011FEB1BQ33636419-E8FE9229-0566-4D07-840D-7C16CC5A8C65Q34055922-BA5782FC-6B12-4DA9-A8EE-04F3E92C8420Q34179727-C4B66E3B-A38B-4987-BAC9-3A584DF58F68Q34186949-A68D5235-1A4D-460B-BBE7-0826DE463E5AQ34190118-224B81D3-917A-4E83-AB28-AF7271672980Q34393424-07B723F7-D03B-4A65-87E0-CF2B1C1DB0A0Q34521850-8F9C89FD-1B75-47D5-8544-DACF84170D4DQ35821653-F441D4DB-E1BC-4FEE-BFC1-17A47007AEC0Q36433783-9C7A0C6A-F4D1-4607-9CE1-616DA0D3F30FQ36689177-5E670907-1CB7-47A3-A99F-72FDBFA910D3Q36856987-C4287DD7-84D1-4B6E-B50C-4ACC1A07581BQ37223970-7D4CC4A3-2A33-4E9D-BE84-2B275DE8CA03Q37325934-61C886B7-63A0-430D-85F0-C8B4E91F34ABQ37472274-B312C355-32A7-4F90-8DCB-269FD4773B8EQ37533694-9DBA7F79-7225-4669-87CA-720F79E3E72AQ37999094-CD3E741D-21B1-464B-A8D3-C32B44E861E4Q38111723-5A8B6D15-605F-41B7-AF2D-6D4494946F70Q38132922-077802A1-E249-4F56-A0CC-C41922A8537DQ38357176-D3AAD649-5105-4879-969A-D5D6A4F7E7C7Q39161614-8CC7C47E-4D4D-47A6-AC0F-022E9AB72523Q39615733-F71A17AA-17C0-4B7B-8C6D-811BF054C693Q40195489-C91EF34E-C287-4AFB-9622-6D27949FBEDAQ40470795-FA133630-4CFC-4C5A-92EB-9B154A19BFF0Q40699417-29E1DAA7-CD29-45B7-BCB1-A09147525435Q40781723-EB49ACA6-F3C7-4C20-8455-97920A73A55BQ40817535-418EDD79-93A1-46FD-9A58-6228C1C3D4A1Q40868686-3B2C3179-7783-448C-A299-923960FA8791Q41620695-C938779A-2E3E-4533-9C9F-4971FF2722A0Q42380795-348A0C97-3C49-45FA-8C8B-7905197E4DEBQ43070116-EE7DF0B4-FAC9-4291-A468-8EF1D984F6C1Q44413011-568DCDC9-75C8-4E21-8B19-CCDF81E6C8AFQ46394327-034E3BD7-E09F-4B4A-AB26-047C4744FD2AQ52120808-0E553057-284D-4128-93F7-576756AD1BDE
P2860
Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Activation of FP prostanoid re ...... and in the cell cytoskeleton.
@en
type
label
Activation of FP prostanoid re ...... and in the cell cytoskeleton.
@en
prefLabel
Activation of FP prostanoid re ...... and in the cell cytoskeleton.
@en
P2093
P2860
P356
P1476
Activation of FP prostanoid re ...... and in the cell cytoskeleton.
@en
P2093
P2860
P304
35944-35949
P356
10.1074/JBC.274.50.35944
P407
P577
1999-12-01T00:00:00Z